Kwmg LLC Has $14.67 Million Stake in Cardinal Health, Inc. (NYSE:CAH)

Kwmg LLC reduced its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 1.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 131,061 shares of the company’s stock after selling 1,453 shares during the period. Cardinal Health comprises about 1.6% of Kwmg LLC’s investment portfolio, making the stock its 16th largest holding. Kwmg LLC owned 0.05% of Cardinal Health worth $14,666,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. Cornerstone Wealth Management LLC acquired a new stake in Cardinal Health during the 4th quarter worth approximately $209,000. Mather Group LLC. lifted its holdings in Cardinal Health by 2.5% during the 4th quarter. Mather Group LLC. now owns 6,678 shares of the company’s stock worth $673,000 after purchasing an additional 164 shares during the last quarter. Cambridge Investment Research Advisors Inc. lifted its holdings in Cardinal Health by 86.8% during the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 69,423 shares of the company’s stock worth $6,998,000 after purchasing an additional 32,250 shares during the last quarter. Nordea Investment Management AB raised its holdings in Cardinal Health by 50.5% in the 4th quarter. Nordea Investment Management AB now owns 184,537 shares of the company’s stock valued at $18,649,000 after acquiring an additional 61,933 shares in the last quarter. Finally, Vest Financial LLC raised its holdings in Cardinal Health by 15.9% in the 4th quarter. Vest Financial LLC now owns 282,440 shares of the company’s stock valued at $28,470,000 after acquiring an additional 38,769 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Shares of NYSE:CAH traded down $2.17 during midday trading on Wednesday, reaching $100.96. The company’s stock had a trading volume of 1,075,059 shares, compared to its average volume of 2,195,128. The firm has a market capitalization of $24.59 billion, a price-to-earnings ratio of 44.95, a PEG ratio of 1.17 and a beta of 0.64. The firm has a 50 day moving average price of $100.31 and a two-hundred day moving average price of $104.65. Cardinal Health, Inc. has a fifty-two week low of $85.11 and a fifty-two week high of $116.04.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.95 by $0.13. The company had revenue of $54.90 billion for the quarter, compared to the consensus estimate of $56.05 billion. Cardinal Health had a negative return on equity of 54.74% and a net margin of 0.25%. The firm’s revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.74 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.35 earnings per share for the current year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Investors of record on Monday, July 1st will be paid a dividend of $0.5056 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.50. This represents a $2.02 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date is Monday, July 1st. Cardinal Health’s dividend payout ratio is 88.89%.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on CAH. Wells Fargo & Company dropped their price objective on Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a report on Monday, April 29th. StockNews.com upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Monday. Argus decreased their price target on Cardinal Health from $120.00 to $115.00 and set a “buy” rating on the stock in a research note on Wednesday, May 15th. Evercore ISI lifted their price target on Cardinal Health from $110.00 to $115.00 and gave the company an “in-line” rating in a research note on Friday, May 3rd. Finally, Robert W. Baird decreased their price target on Cardinal Health from $134.00 to $128.00 and set an “outperform” rating on the stock in a research note on Friday, May 3rd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $109.67.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.